Moleculin Biotech, Inc.

MBRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$6,703$7,557$7,716$4,278
Short-Term Investments$0$0$0$0
Receivables$6$5$6$0
Inventory$0$0$0$0
Other Curr. Assets$1,176$1,514$1,618$916
Total Curr. Assets$7,885$9,076$9,340$5,194
Property Plant & Equip (Net)$420$469$525$583
Goodwill$0$0$0$0
Intangibles$11,148$11,148$11,148$11,148
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$900$900$0$0
Total NC Assets$12,468$12,517$11,673$11,731
Other Assets$0$0$0$0
Total Assets$20,353$21,593$21,013$16,925
Liabilities
Payables$2,116$3,721$2,706$2,030
Short-Term Debt$132$128$124$120
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,434$4,064$4,066$3,209
Total Curr. Liab.$5,682$7,913$6,896$5,359
LT Debt$258$292$326$358
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$41,333$20,553$13,749$5,229
Total NC Liab.$41,591$20,845$14,075$5,587
Other Liabilities$0$0$0$0
Cap. Leases$258$292$326$478
Total Liabilities$47,273$28,758$20,971$10,946
Equity
Pref Stock$0$0$0$0
Common Stock$49$30$14$3
Retained Earnings-$221,556-$167,443-$159,803-$153,367
AOCI-$44-$38-$38-$41
Other Equity$194,631$160,286$159,869$159,384
Total Equity-$26,920-$7,165$42$5,979
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,353$21,593$21,013$16,925
Net Debt-$6,313-$7,137-$7,266-$3,800
Moleculin Biotech, Inc. (MBRX) Financial Statements & Key Stats | AlphaPilot